| Title |
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
|
|---|---|
| Published in |
Diabetes Therapy, July 2019
|
| DOI | 10.1007/s13300-019-0657-8 |
| Pubmed ID | |
| Authors |
Amar Ali, Steve Bain, Debbie Hicks, Phillip Newland Jones, Dipesh C. Patel, Marc Evans, Kevin Fernando, June James, Nicola Milne, Adie Viljoen, John Wilding |
X Demographics
The data shown below were collected from the profiles of 47 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 26 | 55% |
| United States | 1 | 2% |
| Russia | 1 | 2% |
| India | 1 | 2% |
| Ireland | 1 | 2% |
| Pakistan | 1 | 2% |
| Canada | 1 | 2% |
| France | 1 | 2% |
| Unknown | 14 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 57% |
| Practitioners (doctors, other healthcare professionals) | 12 | 26% |
| Scientists | 5 | 11% |
| Science communicators (journalists, bloggers, editors) | 3 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 86 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 14% |
| Other | 6 | 7% |
| Researcher | 5 | 6% |
| Student > Master | 5 | 6% |
| Student > Ph. D. Student | 4 | 5% |
| Other | 14 | 16% |
| Unknown | 40 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 35% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Nursing and Health Professions | 2 | 2% |
| Engineering | 2 | 2% |
| Other | 5 | 6% |
| Unknown | 42 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2021.
All research outputs
#1,276,925
of 25,002,811 outputs
Outputs from Diabetes Therapy
#47
of 1,125 outputs
Outputs of similar age
#27,262
of 352,335 outputs
Outputs of similar age from Diabetes Therapy
#2
of 24 outputs
Altmetric has tracked 25,002,811 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,125 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,335 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.